Published in CMAJ on August 13, 2012
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Management of adult patients with ascites due to cirrhosis: an update. Hepatology (2009) 5.26
Management of bacterial infections in cirrhosis. J Hepatol (2012) 1.54
Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res (2007) 1.41
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf (2009) 1.31
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases. Hepatology (2009) 1.12
Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis (2005) 1.09
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ (2012) 0.96
Hepatic adverse drug reactions: a case/non-case study in Italy. Eur J Clin Pharmacol (2006) 0.93
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol (2003) 3.04
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology (2011) 2.25
Liver transplantation for hepatocellular carcinoma. Gastroenterology (2005) 2.15
Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl (2013) 2.07
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology (2013) 1.81
Impact of nighttime and weekend liver transplants on graft and patient outcomes. Liver Transpl (2012) 1.60
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity. Clin Gastroenterol Hepatol (2005) 1.57
Right hepatic lobe donation adversely affects donor life insurability up to one year after donation. Liver Transpl (2005) 1.46
Greater travel time to a liver transplant center does not adversely affect clinical outcomes. Liver Transpl (2008) 1.45
Local access to subspecialty care influences the chance of receiving a liver transplant. Liver Transpl (2013) 1.43
IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology (2014) 1.15
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol (2013) 1.10
Autoimmune hepatitis triggered by statins. J Clin Gastroenterol (2006) 1.06
Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol (2011) 1.05
The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol (2011) 0.89
Complete reversal of glycogen hepatopathy with pancreas transplantation: two cases. Transplantation (2007) 0.87
Depression in primary caregivers of patients listed for liver or kidney transplantation. Prog Transplant (2007) 0.86
Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population. J Clin Gastroenterol (2013) 0.85
Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma. Liver Int (2007) 0.85
Cat scratch disease causing hepatic masses after liver transplant. Liver Int (2007) 0.84
Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness. Clin Gastroenterol Hepatol (2010) 0.84
Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Dig Dis Sci (2009) 0.84
Effect of ERCP utilization and biliary complications on post-liver-transplantation mortality and graft survival. Dig Dis Sci (2010) 0.83
Severe liver injury after initiating therapy with atomoxetine in two children. J Pediatr (2006) 0.80
Long-term survival after 67 hours of anhepatic state due to primary liver allograft nonfunction. Liver Transpl (2010) 0.80
Re: nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2013) 0.78
Acute liver failure due to iron overdose in an adult. South Med J (2005) 0.76
Progress in our understanding of severe drug-induced liver injury. Liver Transpl (2009) 0.75
Insulin resistance, hepatitis C, and liver transplantation. Liver Transpl (2008) 0.75
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation. Curr Hepat Rep (2011) 0.75
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol (2016) 0.75
Focal fat masquerading as malignancy in the liver graft of a post-transplant patient. Dig Dis Sci (2011) 0.75
Metabolic syndrome following liver transplantation is associated with major vascular events. Liver Transpl (2007) 0.75
Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy. Liver Transpl (2007) 0.75
Appendiceal mucinous tumor. Gastroenterology (2002) 0.75
Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration. Transplantation (2017) 0.75
Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast! Postgrad Med (2004) 0.75
Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes. J Clin Gastroenterol (2017) 0.75